Contribute to research on the path to Net Zero

Researchers based at Oxford Brookes Business School are conducting a survey that will gather information about business’ understanding of the UK government’s pledge to achieve net-zero, as well as examining business’ current planning and activity towards lowering carbon emissions.

The Net Zero Strategy sets out how the UK will deliver on its commitment to reach net zero emissions by 2050. For an overview about the UK government’s policies and proposals for decarbonising all sectors of the UK economy to meet the net zero target by 2050, click here.

If you represent a small or medium sized enterprise (SME), that is, your business employs fewer than 250 members of staff, you are invited to participate in this research.

All responses to this study will be kept confidential. All data collected will be analysed and showcased anonymously. A final report showcasing aggregated data will be available via the webpage for the Oxford Regions, Innovation and Enterprise Lab (ORIEL). The data will only be accessible to the researchers involved in the study. Data files will be password encrypted, securely stored and never used on a shared computer. If you have any concerns about the conduct of the study you may contact the Chair of the Oxford Brookes University Research Ethics Committee [email protected].

To take part in this research project Please click here  

Recent news

Benedicts joins CBRE as joint agents for Milton Park

Benedicts joins CBRE as joint agents for Milton Park

Milton Park, the UK’s largest single ownership innovation community, has appointed Benedicts to join CBRE as joint leasing agents for the 2.8 million sq ft Park. Milton Park welcomed over 40 new occupiers in 2025 and is now home to more than 280 innovative companies....

read more
Launch of the BioEscalator Annual Review – 2024/25

Launch of the BioEscalator Annual Review – 2024/25

People and partnerships driving better patient health The BioEscalator is the University of Oxford’s thriving incubator for fast-growing biomedical companies. In 2024/25 it worked with people and organisations across the local and global innovation ecosystem and it’s...

read more
Loading...